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Complete S1 gene of the Infectious Bronchitis Virus (IBV) was amplified and cloned into transfer vector. 
Truncated S1 gene designated as Sf200 (containing five antigenic sites located at 24–61, 291–398 and 
497–543 amino acid residues of S1 glycoprotein) were amplified by overlap PCR, cloned into prokaryotic 
expression vector resulting pET-Sf200 and confirmed the construct by sequencing. The recombinant 
plasmid was identified by restriction enzyme and sequencing analysis. The in vitro expression of the 
truncated protein was analyzed in E. coli with a molecular weight of 38kDa determined through SDS-
PAGE and confirmed by Western blotting. The recombinant truncated protein was then purified from the 
culture media. The immunogenicity of the protein was studied in an animal experiment on mice, in which 
mice were injected subcutaneously. These findings suggest that the truncated Sf200 expressed in the pET-
32a (+) prokaryotic vector can be used as antigen to detect antibodies against IBV.
INTRODUCTION
Infectious Bronchitis Virus (IBV) belong to Cornoaviridae family is the etiological agent of Infectious Bronchitis 
(IB) disease in poultry. This disease is highly contagious 
and has economic significance due to decreased egg 
production and quality. The main clinical manifestations 
in affected birds are related to respiratory problems. 
However, it causes extensive damage to in various parts 
of the body including kidney and the oviduct (Cavanagh, 
2003; Yu et al., 2001; Liu and Kong, 2004). In many 
reports, the nephropathic lesion have been observed in 
vaccinated flocks which strongly suggest that the currently 
used IB vaccination may not providing good protection 
(Cavanagh and Naqi, 1997).
The IBV encodes four major structural proteins, 
known as, envelope (E) protein, membrane (M) protein, 
nucleocapsid (N) protein and spike (S) glycoprotein. 
The spike glycoproteins are synthesized as precursor 
glycoprotein which post translationally cleaved into two 
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subunits, S1 and S2. The S1 subunit plays an important role 
in the attachment of the virus to the host cell membrane as it 
carries receptors for the virus attachment. The neutralizing 
epitopes for induction of T cytotoxic lymphocytes as 
well as induction of antibodies for virus neutralization 
are also present in S1 (Kant et al., 1992; Koch et al., 
1990). The amino acid sequence of S1 subunit is highly 
variable (Cavanagh et al., 1992) however, some studies 
have demonstrated that it was an excellent candidate for 
developing recombinant vaccines, monoclonal antibodies 
(mAbs) and polyclonal for developing the diagnostic 
reagents as compared to other structural proteins (Wang 
et al., 2002; Johnson et al., 2003). The expression of 
Spike gene has been reported in various prokaryotic and 
eukaryotic expression systems (Jain et al., 2017; Sepideh 
et al., 2012; Zhou et al., 2003).
In this study, keeping in view the antigenic mapping 
regions in S1 of IBV (as the complete S1 about 1650 base 
pairs (bp) is very difficult to be expressed in Escherichia 
coli (E. coli) we expressed truncated spike polypeptide 
antigen produced in E. coli designated as Sf200 {(truncated 
S1 having five antigenic regions on amino acids residues 
(aa) 24–61 (S1D), (aa) 291–398 (S1CAB) and (aa) 497–
543 (S1F)} construct was cloned into pET-32a (+) vector 
A B S T R A C T
Pakistan J. Zool., vol. 50(3), pp 989-994, 2018. DOI: http://dx.doi.org/10.17582/journal.pjz/2018.50.3.989.994
990                                            
and expressed in E. coli BL21. The polyclonal antibodies 
were developed in mice by using the recombinant Sf200 
protein inoculated into mice. The polyclonal antibodies 
were used to identify the recombinant adenovirus as well 
as E. coli expressed Sf200 protein.
MATERIALS AND METHODS
Animals, virus and sera
A new highly virulent nephropathogenic IBV strain 
named CK/CH/XDC-2/2013 field strains of IBV Gene 
bank accession number KM213963 were isolated from 
the chickens showing typical signs and postmortem lesion 
of the disease. The virus was propagated into 9 days old 
specific pathogen-free (SPF) embryos. The eggs were 
harvested immediately if there was death of the embryo 
noticed by candling. The 50% Embryo infective dose 
(EID50) was calculated by inoculating serial 10-fold 
dilutions of virus into SPF embryonated chicken eggs. 
Four-week-old SPF BALB/c mice were purchased local 
suppliers. The serum samples collected from the mice 
were stored at -20°C until used.
Total RNA extraction and cDNA synthesis
The total RNA was extracted from the allantoic 
fluid using TRIzol reagent (Thermo Fisher Scientific) 
according to the manufacturer’s protocol. RNA pellet was 
dried, re-suspended and washed by ethanol. The pellet 
was suspended in diethyl pyrocarbonate (DEPC) treated 
water and processed immediately for subsequently cDNA 
preparations. For reverse transcription 3µl (0.5µg/ µl) total 
RNA was used at 37°C for 1h using 1µl Oligo (Oligo(dT) 
10pmol/µl), 0.5µl dNTP (7.5Mm/ µl), 5X RT buffer 
and 0.5µl (200U/µl) of M-MLV Reverse transcriptase 
(Promaga, USA). 
Amplification, cloning of S1 and selection of protein gene 
Sf200
Conventional PCR was performed in thermocycler 
(Eppendorff Mastercycler, USA). Three pairs of primers 
were designed to amplify complete S1 gene of IBV (Table 
I) and cloned into pMD18-T vector using 25µl total 
volume mixture containing 12.5µl PCR master mix, 3µl 
cDNA, 0.5µl (10 pmol) of each pair of primer (listed in 
Table I) and 8.5µl of ddH2O. Three fragments of 150 bp, 
351 bp, and 162 bp were amplified using primers (Table 
I). PCR Reaction was carried out at different annealing 
temperature and extension time depending on fragment 
lengths (Table I). Amplified products were visualized 
and photographed by digital Gel Doc Transilluminator 
imaging system (Hamamatsu, Japan) at 1% agarose gel 
electrophoresis. 
Construction of plasmid pET-32a-Sf200
After amplification of these three fragments, they 
were ligated with overlap PCR. The PCR products were 
purified and sub-cloned into a prokaryotic expression 
pET-32a (+) vector (Novagen, USA). The recombinant 
expression plasmid was constructed as pET-Sf200 and 
confirmed by sequencing analysis.
Expression of recombinant Sf200 protein
The transformed E. coli BL21 containing the 
recombinant plasmid was propagated in LB broth 
containing ampicillin (0.1 mg/ml) overnight at 37°C with 
rapid shaking (160 rpm). In order to make the culture fresh, 
one milliliter of overnight grown bacterial was inoculated 
into 100 ml of fresh LB broth with ampicillin antibiotic at 
0.1 mg/ml. When the OD600 reached 0.6, the culture was 
induced by adding isopropyl β-d-1-thiogalactopyranoside 
(IPTG) of 1 mM followed by further incubation for 
four hours on shaker. Under the optimized expression 
conditions, 100 ml of bacterial culture was collected and 
centrifuged at 12000 g for 30 min at room temperature. 
The resultant pellets were re-suspended with 1/10 volume 
of Buffer A (100 mm NaH2PO4.2H2O, 10 mm Tris base 
and 8 m urea, pH 8.0) and then sonicated on ice. 
Purification of recombinant Sf200 protein
The fusion protein expressed by recombinant pET-
32 α (+) vector contains His-Tag which is often used 
for affinity purification by Ni-NTA spin kit according 
to manufacturer’s protocol (Qiagen). Briefly, the 
supernatant was collected after centrifugation at 12000 g 
for 30 min at 4°C, and slowly added onto Ni-NTA affinity 
chromatography column balanced with 8 ml Buffer B 
(100 mm NaH2PO4.2H2O, 10 mm Tris-base and 8 m 
urea, pH 6.3). Buffer C (100 mm NaH2PO4.2H2O, 10 mm 
Tris-base and 8 m urea, pH 5.9) and Buffer D (100 mm 
NaH2PO4.2H2O, 10 mm Tris-base and 8 m urea, pH 4.5) 
with 4 ml each were used to elute the bound protein and the 
eluted solution was collected in 1 ml aliquot. The protein 
bands were separated by SDS-PAGE and the truncated 
protein was detected by Western Blot.
Immunogenicity studies in mice
Generation of polyclonal antibodies
The purified recombinant pET-Sf200 protein emulsified 
with Freund’s complete adjuvant was injected into five 
BALB/c mice through subcutaneously (S/C) route using 26 
gauge needle with an infectious dose of 50μg per mouse. 
The second booster dose was injected at 21 days S/C 
route. The last third booster dose of the antigen emulsified 
with Freund’s incomplete adjuvant was injected at 40 
days through intraperitoneal (I/P) route. The mice were 
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sacrificed after two weeks at days and the blood samples 
were collected.
SDS-PAGE and Western blot analysis
The molecular weight of the E.coli expressed Sf200 
protein was estimated by running it on SDS-PAGE 
electrophoresis (run through the stacking gel at 50 V. Then, 
the resolving gel was run at 100 V) followed by western 
blotting to in order to determine the binding properties 
and immunoreactivity with minor modifications of the 
method described by Zeshan et al. (2011) and Calandrella 
et al. (2001). Firstly the protein samples were boiled 
in water bath for five minutes and loaded to the SAD-
PAGE 10% gel for 45 min. The bands were transferred 
to nitrocellulose membrane and probed using polyclonal 
antibodies raised in mice. Secondary antibody i.e. goat 
anti-mouse IgG conjugated with horseradish peroxidase 
(Boster Bio-Tech.) was used at the dilution of 1:3000 in 
PBS-T. Proteins were visualized using chemiluminescence 
luminol reagents (Thermo Scientific Super Signal West 
Femto Maximum Sensitivity Substrate). After developing 
the band, the membrane was washed with water to remove 
the substrate solution.
RESULTS
Cloning and sequence analysis of S1 gene
RNA was extracted from the allantoic fluid containing 
IBV virus and cDNA was constructed. Using set of primers 
(Table I), the complete S1 gene of IBV was amplified 
by RT-PCR and cloned into pMD-18 T vector resulting 
pMD-18 T-S1. The ligation was confirmed by restriction 
enzyme digestion and sequencing (Fig. 1). The proper 
open reading frame (ORF) of the gene was checked upon 
sequence analysis which was right followed by BLAST 
in NCBI, Gene Bank, which showed 99% similarity with 
IBV nephropathogenic strain isolated from Hebei, China.
Cloning of Sf200 by overlap PCR and expression and 
identification of prokaryotic recombinant
Three fragments of 150 bp, 351 bp and 162 bp were 
amplified from pMD-18 T-S1 with the help of forward and 
reverse primers as shown in Table I. The PCR products 
were run at 1% agarose gel. The three fragments were 
joined together by overlap PCR with 660 bp size (Fig. 
2). Proper ligation and of the overlapped fragments was 
confirmed by sequencing and restriction enzyme analysis 
using BamHI and XhoI (Fig. 3).
Fig. 1. Gel electrophoresis showing restriction enzyme 
digestion of complete S1 gene (1650bp approx.) after 
digestion with XhoI while 1kb DNA ladder is on the other 
side.
Table I.- Primer sequences, PCR Conditions and restriction enzyme sites complete S1 and truncated S1 gene 
fragments of field strain of IBV.
S No. Primer ID Sequence Enzyme site Gene ID (Size) PCR conditions
1 S1-F 5' GCGCTCGAGATGTTGGGGAAGTCACTG 3' XhoI S1 (1650) Denaturation: 94°C/45s
Annealing: 60°C/45s
Extension: 72°C/60s2 S1-R 5' CGCCTCGAGTTACATTTTGGTCATAGAA 3 XhoI
3 Sense 1 5' GCGGGATCCATGGATAGTTATGTTT 3' BamHI S1D (150bp) Denaturation: 94°C/45s
Annealing: 56°C/30s
Extension: 72°C/20s4 Anti 1 5' CACCACCTTTATTGCCTGCATTATT 3' No site
5 Sense 2 5' CAGGCAATAAAGGTGGTGTTGATAC 3' No site S1CAB (351bp) Denaturation: 94°C/45s
Annealing: 53°C/30s
Extension: 72°C/30s6 Anti 2 5' CCTCACAAGGCTGCGTCAATTCACC 3' No site
7 Sense 3 5' TGACGCAGCCTTGTGAGGATGTTAA 3' No site S1F (162bp) Denaturation: 94°C/45s
Annealing: 60°C/30s
Extension: 72°C/20s8 Anti 3 5' TATCTCGAGTTACCTGGAACGACG 3' XhoI
Immunogenicity of Truncated Spike Protein of IBV in Mice 991
992                                            
Fig. 2. Amplification of three fragments of S1 with the size 
of 150bp, 162bp and 351bp, respectively. Arrow indicate 
1kb DNA ladder.
Fig. 3. Restriction enzyme analysis of pET-32a-Sf200 after 
digestion with BamHI and XhoI (Lane 1, 3). 1kb DNA 
ladder is on the other side.
Fig. 4. SDS-PAGE of the Purified Sf200 Lane (1) and the 
cell lysate of E. coli harboring the recombinant plasmid 
pET-32a-Sf200 (38kDa approx.) after induction with IPTG 
containing E. coli BL21 (Lane 4), E. coli Rosetta strain 
(Lane 5), before induction with IPTG (Lane 2), pET-32a 
(+) vector control (Lane 3) while the proteins standards are 
showed on right side of panel.
SDS-PAGE and Western blotting
After induction by 1 mm IPTG at 37°C for 4 h, the 
Sf200 proteins were found in the inclusion bodies in cell 
lysate of E. coli BL21 (DE3) with the molecular weight 
of around 40 kDa, approx. which was consistent with 
the predicted values, and recognized by mouse anti-S1 
polyclonal antibodies as well as the homologous chicken 
anti-IBV serum (Fig. 5). The expressed Sf200 protein was 
purified, and their corresponding yields in bacteria culture 
were calculated to be determined by presence of 2.5 mg of 
pure S1 protein. Additionally, we also expressed the full-
length of S1 protein or fragments of S1 protein in E. coli. 
Unfortunately, this protein can be expressed at very low 
level.
Fig. 5. Western blot analysis prokaryotic expressed Sf200 
in BL21 E. coli (Lane 2), while the proteins standards are 
showed on left side of panel.
DISCUSSION
Avian IBV is a significant pathogen of commercial 
poultry causing huge economic losses to the poultry 
industry worldwide. The severity of the disease is increased 
by the secondary bacterial infection leading to chronic 
complicated airsacculitis and nephritis. Diagnosis of IB is 
based on virus isolation or demonstration of viral nucleic 
acid and determination of of an ascending serum antibody 
response may also be useful. The S1 protein is a structural 
glycoprotein and is a key factor of virus neutralization and 
so is an excellent candidate for development of the novel 
IBV vaccines. S1 gene has also been used for development 
of ELISA kits (Gomaa et al., 2009; Hu et al., 2007; Loa et 
al., 2004).
In this study, Sf200 protein S1 gene of field strain 
of IBV was expressed in E. coli BL21 strain at a higher 
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level using a prokaryotic pET32a (+) vector system. The 
expressed proteins can bind further with mouse anti-
IBV serum, indicating that the recombinant Sf200 protein 
is a potential valuable antigen for developing to detect 
antibody of IBV S1 protein and for an engineering subunit 
vaccine against IBV. The S1 region carries the receptor 
binding domain that defines tissue and host tropisms. 
Besides, it is responsible for serotype variability among 
IBV isolates (Sepideh et al., 2012). However, IBV S1 
protein is characterized by presence of a signal peptide 
domain at the extreme 5′ end of the gene that was found to 
block successful cloning and expression of the complete 
S1 gene. To overcome this, a fragment of the S gene was 
selected for cloning and expression based on B cell epitope 
prediction (Larsen et al., 2006).
The observed molecular mass at 38 kDa of the 
expressed fusion Sf200 protein is within the expected range. 
There are additional amino acids for the histidine tag in 
the C-terminal of the expressed fusion protein. These extra 
amino acids increase the molecular mass of expressed 
target protein.
Therefore, in future research, the specific location 
of amino acid residues involved in the epitopes needs 
to be further examined by mAbs as well as by using 
prokaryotic expression of S1 cDNA overlapping peptides. 
A preliminary ELISA method using the recombinant S1 
protein as coating antigen could also be developed, which 
would have industrial application as well. A recombinant 
partial S1 protein has the potential to be used as a 
recombinant Ag in diagnostic kits in future.
Statement of conflict of interest
Authors have declared no conflict of interest.
REFERENCES
Calandrella, M., Matteucci, D., Mazzetti, P. and Poli, A., 
2001. Densitometric analysis of western blot assays 
for feline immunodeficiency virus antibodies. Vet. 
Immunol. Immunopathol., 79: 261-271. https://doi.
org/10.1016/S0165-2427(01)00265-3
Cavanagh, D., 2003. Severe acute respiratory syndrome 
vaccine development: Experiences of vaccination 
against avian infectious bronchitis coronavirus. 
Avian Pathol., 32: 567-582. https://doi.org/10.108
0/03079450310001621198
Cavanagh, D. and Naqi, S., 1997. Infectious bronchitis. 
In: Diseases of poultry (eds. B.W. Calnek, H.J. 
Barnes, L.R. McDougald and Y.M. Saif), 10th ed. 
London, pp. 511-526
Cavanagh, D., Davis, P.J., Cook, J.K., Li, D., Kant, A. 
and Koch, G., 1992. Location of the amino acid 
differences in the S1 spike glycoprotein subunit of 
closely related serotypes of infectious bronchitis 
virus. Avian Pathol., 21: 33-43. https://doi.
org/10.1080/03079459208418816
Jain, S.K., Jain, H. snd Bedekar, M.K. 2017. Expression 
of immunogenic S1 gene of infectious bronchitis 
virus from field outbreak in Eukaryotic cells. J. 
Anim. Res., 7: 27-32. https://doi.org/10.5958/2277-
940X.2017.00005.5
Johnson, M.A., Pooley, C., Ignjatovic, J. and Tyack, 
S.G., 2003. A recombinant fowl adenovirus 
expressing the S1 gene of infectious bronchitis 
virus protects against challenge with infectious 
bronchitis virus. Vaccine, 21: 2730-2736. https://
doi.org/10.1016/S0264-410X(03)00227-5
Kant, A, Koch, G., van Roozelaar, D.J., Kusters, J.G., 
Poelwijk, F.A.J. and van der Zeijst, B.A.M., 1992. 
Location of antigenic sites defined by neutralizing 
monoclonal antibodies on the S1 avian infectious 
bronchitis virus glycopolypeptide. J. Gen. Virol., 
73: 591-596. https://doi.org/10.1099/0022-1317-
73-3-591
Koch, G., Hartog, L., Kant, A. and van Roozelaar, D.J., 
1990. Antigenic domains on the peplomer protein 
of avian infectious bronchitis virus: Correlation 
with biological functions J. Gen. Virol., 71: 1929-
1935. https://doi.org/10.1099/0022-1317-71-9-
1929
Larsen, J.E., Lund, P.O. and Nielsen, M., 2006. 
Improved method for predicting linear B-cell 
epitopes. Immunol. Res., 2: 1-7.
Liu, S. and Kong, X., 2004. A new genotype of 
nephropathogenic infectious bronchitis virus 
circulating in vaccinated and non-vaccinated flocks 
in China. Avian Pathol., 33: 321-327. https://doi.
org/10.1080/0307945042000220697
Sepideh, G., Hosseni, S.D., Zolfaghari, M.R. and 
Masoodi, S., 2012. Expression of S1 glycoprotein 
gene of infectious bronchitis virus (IBV) in 
Escherichia coli. Afri. J. Microbiol. Res., 6: 3139-
3143.
Wang, C.H., Hong, C.C. and Seak, J.C., 2002. An ELISA 
for antibodies against infectious bronchitis virus 
using an S1 spike polypeptide. Vet. Microbiol., 
85: 333-342. https://doi.org/10.1016/S0378-
1135(01)00525-9
Yu, L., Wang, Z., Jiang, Y., Low, S. and Kwang, J., 2001. 
Molecular epidemiology of infectious bronchitis 
virus isolates from China and Southeast Asia. Avian 
Dis., 45: 201-209. https://doi.org/10.2307/1593029
Zhou, J.Y., Wu, J.X., Chen, L.Q., Zheng, X.J., 
Gong, H., Shang, S.B. and Zhou, E.M., 2003. 
994                                            B. Zeshan et al.
Expression of immunogenic S1 glycoprotein of 
infectious bronchitis virus in transgenic potatoes. 
J. Virol., 77: 9090-9093. https://doi.org/10.1128/
JVI.77.16.9090-9093.2003
Zeshan, B., Mushtaq, M.H., Wang, X., Li, L. and 
Jiang, P., 2011. Protective immune responses 
induced by in ovo immunization with recombinant 
adenoviruses expressing spike (S1) glycoprotein of 
infectious bronchitis virus fused/co-administered 
with granulocyte-macrophage colony stimulating 
factor. Vet. Microbiol., 148: 8-17. https://doi.
org/10.1016/j.vetmic.2010.08.003
Hu, J.Q., Li, Y.F., Guo, J.Q., Shen, H.G., Zhang, D.Y. and 
Zhou, J.Y., 2007. Production and characterization 
of monoclonal antibodies to poly100S1 protein 
of avian infectious bronchitis virus. Zoon. Publ. 
Hlth., 54: 69-77. https://doi.org/10.1111/j.1863-
2378.2007.01030.x
Gomaa, M.H., Yoo, D., Ojkic, D. and Barta, J.R., 
2009. Use of recombinant S1 spike polypeptide 
to develop a TCoV-specific antibody ELISA. Vet. 
Microbiol., 138: 281-288. https://doi.org/10.1016/j.
vetmic.2009.04.010
Loa, C.C., Lin, T.L., Wu, C.C., Bryan, T.A., Hooper, T. 
and Schrader, D., 2004. Expression and purification 
of turkey coronavirus nucleocapsid protein in 
Escherichia coli. J. Virol. Methods, 116: 161-167. 
https://doi.org/10.1016/j.jviromet.2003.11.006
